A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach
Completed
Johnson & Johnson Consumer and Personal Products Worldwide
Phase 4
1969-12-31
The purpose of this study is to compare several analgesics given in approved daily doses in
combination with a daily cardioprotective dose of aspirin (81 mg), to study their bleeding
properties and their effects on the stomach in healthy volunteers.
Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols
Unknown status
Merck Sharp & Dohme Corp.
Phase 4
2008-12-01
The investigators will study 2 doses of etoricoxib to prove that 60 mg once daily will be
non-inferior to etoricoxib 90mg daily (for 14 days) in the treatment of acute ankle sprain in
sports. The investigators objective is to discuss the point that the investigators will
follow the minimal dose that is effective for the treatment of this acute condition in
orthopedic.
Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols
Unknown status
Núcleo de Estudos em Esportes e Ortopedia, Brazil
Phase 4
2008-12-01
The investigators will study 2 doses of etoricoxib to prove that 60 mg once daily will be
non-inferior to etoricoxib 90mg daily (for 14 days) in the treatment of acute ankle sprain in
sports. The investigators objective is to discuss the point that the investigators will
follow the minimal dose that is effective for the treatment of this acute condition in
orthopedic.
Caffeine/Propranolol Intervention for Acute Migraine
Completed
Stanford University
Phase 2
2007-01-01
This is a research study to assess the safety of caffeine/propranolol at different dose
levels. We want to find out what effects, good and/or bad, it has on patients and their
migraines.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
